Iris Faull

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Joan Albanell, Antonio González, Manuel Ruíz‐Borrego et al. · Annals of Oncology · 2011 · 120 citations · Full text

Medicine, Oncology, Breast Oncology +10

Genomic profile of advanced breast cancer in circulating tumour DNA

Belinda Kingston, Rosalind Cutts, Hannah Bye et al. · Nature Communications · 2021 · 95 citations · Full text

Medicine, Genetics, Oncology +17

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Joana Vidal, David Casadevall, Beatríz Bellosillo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Surgery +17

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever G. Bivona et al. · Cancers · 2019 · 68 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer

Ramón Palmero, Álvaro Taus, Santiago Viteri et al. · JCO Precision Oncology · 2021 · 63 citations

Medicine, Molecular Medicine, Oncology +17